HAYMAN RAMBARAN: Open Payments
NPI 1639295470 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$650 in 26 payments from 7 companies in 2025. Trend: 2023 $181 · 2024 $731 · 2025 $650
Food & beverage: $650
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 11 | $177 |
| Indivior Inc. | 9 | $170 |
| Gilead Sciences, Inc. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $108 |
| Alkermes, Inc. | 2 | $34 |
| Neuronetics, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $18 |
Products named: BRIXADI, SUBLOCADE, Biktarvy, INGREZZA, VIVITROL, NEUROSTAR TMS THERAPY SYSTEM, MAVYRET.
Industry payments across NJ — which companies pay providers there.
